Synosia Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $143M

Synosia Therapeutics General Information

Description

Developer of products that meets the medical needs in psychiatry and neurology. The company also provides clinical development program and research services.

Contact Information

Website
www.synosia.com
Formerly Known As
Synosis Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Aeschenvorstadt 36
  • 4051 Basel
  • Switzerland
+41 061
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Aeschenvorstadt 36
  • 4051 Basel
  • Switzerland
+41 061

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synosia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Feb-2011 $143M Completed Generating Revenue
4. Later Stage VC (Series C) 12-Oct-2010 Completed Generating Revenue
3. Early Stage VC (Series B) 07-Jan-2009 Completed Generating Revenue
2. Early Stage VC (Series A2) 12-Dec-2007 $10M $42.5M Completed Product Development
1. Early Stage VC (Series A) 05-Jan-2007 $32.5M $32.5M Completed Product Development
To view Synosia Therapeutics’s complete valuation and funding history, request access »

Synosia Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synosia Therapeutics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
5AM Ventures Venture Capital Minority
Abingworth Venture Capital Minority
Aravis Growth/Expansion Minority
Novo Holdings Venture Capital Minority
Patricia Industries PE/Buyout Minority
You’re viewing 5 of 8 investors. Get the full list »

Synosia Therapeutics FAQs

  • When was Synosia Therapeutics founded?

    Synosia Therapeutics was founded in 2005.

  • Where is Synosia Therapeutics headquartered?

    Synosia Therapeutics is headquartered in Basel, Switzerland.

  • What is the size of Synosia Therapeutics?

    Synosia Therapeutics has 17 total employees.

  • What industry is Synosia Therapeutics in?

    Synosia Therapeutics’s primary industry is Drug Discovery.

  • Is Synosia Therapeutics a private or public company?

    Synosia Therapeutics is a Private company.

  • What is the current valuation of Synosia Therapeutics?

    The current valuation of Synosia Therapeutics is .

  • What is Synosia Therapeutics’s current revenue?

    The current revenue for Synosia Therapeutics is .

  • How much funding has Synosia Therapeutics raised over time?

    Synosia Therapeutics has raised $91.1M.

  • Who are Synosia Therapeutics’s investors?

    5AM Ventures, Abingworth, Aravis, Novo Holdings, and Patricia Industries are 5 of 8 investors who have invested in Synosia Therapeutics.

  • When was Synosia Therapeutics acquired?

    Synosia Therapeutics was acquired on 01-Feb-2011.

  • Who acquired Synosia Therapeutics?

    Synosia Therapeutics was acquired by Biotie Therapies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process